Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
Launched by UNIVERSITY HOSPITAL, ANGERS ·
Trial Information
Current as of October 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how chemotherapy treatment for blood cancers—like acute myeloid leukemia, Hodgkin’s lymphoma, and non-Hodgkin’s lymphoma—might affect thinking skills such as memory, attention, and language. Some patients who receive chemotherapy notice problems like trouble concentrating or slower thinking, which can impact daily life and well-being. While these effects are well-known in patients with solid tumors (like breast cancer), less is understood about how chemotherapy affects people with blood cancers. This study aims to better understand these changes by using brain function tests and questionnaires to see how chemotherapy might affect thinking abilities, quality of life, tiredness, anxiety, and depression.
The trial is looking for men and women between the ages of 65 and 74 who are about to start chemotherapy for one of these blood cancers. Participants will complete memory and thinking tests along with questionnaires about how they feel during their treatment. This helps doctors learn more about the possible side effects of chemotherapy on the brain and overall well-being in this group. The study is not yet recruiting, but if you or a loved one fit this age range and diagnosis, this trial might offer insight into managing cognitive difficulties that can come with cancer treatment.
Gender
ALL
Eligibility criteria
About University Hospital, Angers
The University Hospital of Angers is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to investigate new therapeutic approaches and improve patient outcomes. Committed to excellence in patient care and medical education, the University Hospital of Angers collaborates with a network of researchers and healthcare professionals to facilitate groundbreaking studies across various medical fields, ensuring rigorous adherence to ethical standards and regulatory compliance. Through its clinical trial initiatives, the institution aims to contribute significantly to the advancement of medical knowledge and the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported